Fortress Biotech, Inc. - Common Stock (FBIO)
1.8200
+0.0400 (2.25%)
Fortress Biotech Inc is a biopharmaceutical company focused on developing and commercializing innovative therapies and technologies to address unmet medical needs
The company collaborates with various partners to identify and advance novel drug candidates across multiple therapeutic areas, including oncology, dermatology, and rare diseases. By leveraging its diverse portfolio of subsidiaries and strategic collaborations, Fortress aims to bring new treatments to the market and improve patient outcomes. Their approach combines cutting-edge research with robust clinical development strategies to enhance the effectiveness and accessibility of their therapies.
Frequently Asked Questions
Is Fortress Biotech, Inc. - Common Stock publicly traded?
Yes, Fortress Biotech, Inc. - Common Stock is publicly traded.
What exchange does Fortress Biotech, Inc. - Common Stock trade on?
Fortress Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fortress Biotech, Inc. - Common Stock?
The ticker symbol for Fortress Biotech, Inc. - Common Stock is FBIO on the Nasdaq Stock Market
What is the current price of Fortress Biotech, Inc. - Common Stock?
The current price of Fortress Biotech, Inc. - Common Stock is 1.820
When was Fortress Biotech, Inc. - Common Stock last traded?
The last trade of Fortress Biotech, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Fortress Biotech, Inc. - Common Stock?
The market capitalization of Fortress Biotech, Inc. - Common Stock is 50.20M
How many shares of Fortress Biotech, Inc. - Common Stock are outstanding?
Fortress Biotech, Inc. - Common Stock has 27.58M shares outstanding.